Respiratory illness of unknown cause as an early signal of the COVID-19 pandemic

Authors

  • Rosalie Chen Biosecurity Program, The Kirby Institute, Faculty of Medicine and Health, The University of New South Wales, Sydney, NSW, Australia https://orcid.org/0000-0003-3936-9764
  • Mohana Kunasekaran Biosecurity Program, The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia https://orcid.org/0000-0001-5779-7979
  • Aye Moa Biosecurity Program, The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia https://orcid.org/0000-0003-4274-6241
  • Samsung Lim School of Civil and Environmental Engineering, The University of New South Wales, Sydney, NSW, Australia; Biosecurity Program, The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia https://orcid.org/0000-0001-9838-8960
  • Abrar Ahmad Chughtai School of Population Health, The University of New South Wales, Sydney, NSW, Australia; Biosecurity Program, The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia https://orcid.org/0000-0003-4203-7891
  • Elizabeth B Kpozehouen Biosecurity Program, The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia https://orcid.org/0000-0001-8642-7547
  • Xin Chen Biosecurity Program, The Kirby Institute, Faculty of Medicine and Health, The University of New South Wales, Sydney, NSW, Australia
  • Ashley Quigley Biosecurity Program, The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia https://orcid.org/0000-0003-3800-654X
  • C Raina MacIntyre Biosecurity Program, The Kirby Institute, The University of New South Wales, Sydney, NSW, Australia; Watts College of Public Service and Community Solutions, Arizona State University, Phoenix, AZ, United States https://orcid.org/0000-0002-3060-0555

Keywords:

artificial intelligence, COVID-19, disease surveillance, epidemiology, respiratory illness of unknown cause

Abstract

Background: As the COVID-19 pandemic began, cases of respiratory illness of unknown cause could have presented early disease signals. The detection of such signals can provide useful clues regarding disease emergence and opportunities for early outbreak control. This study assessed trends in the global incidence of reports of respiratory illness of unknown cause as early indicators of COVID-19 in late 2019, using the early warning system, EPIWATCH, to investigate the disease’s origins and early epidemiology.

Methods: Global news articles published between 1-Oct and 31-Dec in 2019 and collected by EPIWATCH, an open-source Artificial Intelligence (AI)-driven epidemic surveillance system, were searched for keywords relating to unknown respiratory illness. Control periods representing the pre-COVID period (1-Oct to 31-Dec 2016-2018) were used to compare report trends over time. Data on report location, case demographics, outbreak setting, and type of illness, were extracted and descriptively analysed. Fisher’s exact tests were conducted to assess proportional differences between years.

Results: Overall, 113 EPIWATCH reports of unknown respiratory illness were identified from 12 countries in 2019. Most reports (n=111 [98.2%]) were published in Northern hemisphere countries, in particular Russia (n=A72 [63.7%]) and the United States (n=17 [15.0%]). China experienced a month-on-month increase in reports. Schools were the most reported outbreak setting (n=49 [43.4%]). The proportion of included reports in 2019 was significantly higher compared to 2016-2018 (p<.001).

Conclusion: Potential early COVID-19 signals were detected from various countries before the end of 2019. AI-driven open-source disease surveillance systems, such as EPIWATCH, can provide early warnings to enhance disease surveillance and improve outbreak prevention and response.

Downloads

Published

2024-05-20

How to Cite

Chen, R., Kunasekaran, M., Moa, A., Lim, S., Chughtai, A., Kpozehouen, E., … MacIntyre, C. R. (2024). Respiratory illness of unknown cause as an early signal of the COVID-19 pandemic . Global Biosecurity, 6(1). Retrieved from https://jglobalbiosecurity.com/index.php/up-j-gb/article/view/253

Issue

Vol. 6 (2024)

Section

Research Articles

License

Copyright (c) 2024 The Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:
  1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
  2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
Received 2024-01-03
Accepted 2024-04-12
Published 2024-05-20